Literature DB >> 3199102

Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus.

H E Kennedy1, B V Jones, E M Tucker, N J Ford, S W Clarke, J Furze, L H Thomas, E J Stott.   

Abstract

Six interspecific hybridomas (heterohybridomas) secreting bovine monoclonal antibodies (MAbs) against respiratory syncytial (RS) virus were produced. Four of the heterohybridomas were formed using the mouse myeloma cell line NS1 as the fusion partner, one using NS0, and the remaining heterohybridoma was formed using a bovine X murine hybridoma as the fusion partner. Five heterohybridomas secreted bovine IgG1 and one secreted IgG2. All six MAbs recognized human subtype A and B viruses as well as bovine RS virus. They were specific for the fusion glycoprotein and reacted with a 140K dimer and a 70K monomer in a Western blot of native antigen; three also bound to the 46K F1 component and its 22K cleavage product in a blot of reduced antigen. Two of these MAbs neutralized RS virus infectivity, inhibited virus-induced fusion, lysed RS virus-infected cells in the presence of complement and protected mice against RS virus challenge.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3199102     DOI: 10.1099/0022-1317-69-12-3023

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Comparison of caprine, human and bovine strains of respiratory syncytial virus.

Authors:  M Trudel; F Nadon; C Simard; F Bélanger; R Alain; C Séguin; G Lussier
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 3.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.

Authors:  M Trudel; E J Stott; G Taylor; D Oth; G Mercier; F Nadon; C Séguin; C Simard; M Lacroix
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Antigenic analysis of the F protein of the bovine respiratory syncytial virus: identification of two distinct antigenic sites involved in fusion inhibition.

Authors:  J P Matheise; K Walravens; A Collard; P Coppe; J J Letesson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 7.  The production and application of non-rodent monoclonal antibodies in veterinary science.

Authors:  D J Groves; E M Tucker
Journal:  Vet Immunol Immunopathol       Date:  1989-11-30       Impact factor: 2.046

Review 8.  Molecular Dissection of the Antibody Response: Opportunities and Needs for Application in Cattle.

Authors:  Ruben Barroso; W Ivan Morrison; Liam J Morrison
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

9.  Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves.

Authors:  Geraldine Taylor; Sara Wyld; Jean-Francois Valarcher; Efrain Guzman; Michelle Thom; Stephanie Widdison; Ursula J Buchholz
Journal:  J Gen Virol       Date:  2014-04-03       Impact factor: 3.891

10.  Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.

Authors:  Krister Blodörn; Sara Hägglund; Jenna Fix; Catherine Dubuquoy; Boby Makabi-Panzu; Michelle Thom; Per Karlsson; Jean-Louis Roque; Erika Karlstam; John Pringle; Jean-François Eléouët; Sabine Riffault; Geraldine Taylor; Jean François Valarcher
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.